![Douglas E. Brough](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas E. Brough
Corporate Officer/Principal en PRECIGEN, INC. .
Cargos activos de Douglas E. Brough
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PRECIGEN, INC. | Corporate Officer/Principal | - | - |
Director Técnico/Científico/I+D | - | - |
Historial de carrera de Douglas E. Brough
Antiguos cargos conocidos de Douglas E. Brough.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GENVEC INC | Director Técnico/Científico/I+D | 01/09/2013 | 16/06/2017 |
Formación de Douglas E. Brough.
Purdue University | Undergraduate Degree |
Idaho State University | Graduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Robert Wood Johnson Medical School | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Francia | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 2 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 5 |
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PRECIGEN, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
GenVec, Inc.
![]() GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Douglas E. Brough
- Experiencia